Literature DB >> 27313716

miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer.

Xuexiang Liu1, Jinwan Li1, Fengxian Qin1, Shengming Dai1.   

Abstract

MicroRNAs (miRNAs or miRs) are endogenous translation repressors of protein-coding genes that act by binding to the 3'-untranslated region of their target genes, and may contribute to tumorigenesis by functioning as oncogenes or tumor suppressor genes. miR-152, a member of the miR-148/152 family, is aberrantly expressed in various diseases, including various types of cancer. A growing body of evidence has demonstrated that miR-152 may act as a tumor suppressor gene by regulating its target genes, which are associated with cell proliferation, migration and invasion in human cancer. In the present review, the gene structure and functions of miR-152 are discussed, and in particular, its regulatory mechanism, experimentally validated targets and tumor suppressor role in cancer, are highlighted.

Entities:  

Keywords:  human cancer; hypermethylation; miR-152; tumor suppressor

Year:  2016        PMID: 27313716      PMCID: PMC4888271          DOI: 10.3892/ol.2016.4509

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  50 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II.

Authors:  Tara L Herrmann; Reitu S Agrawal; Sean F Connolly; Ramona L McCaffrey; Jamie Schlomann; David J Kusner
Journal:  J Leukoc Biol       Date:  2007-06-22       Impact factor: 4.962

Review 3.  MicroRNAs grow up in the immune system.

Authors:  Kai P Hoefig; Vigo Heissmeyer
Journal:  Curr Opin Immunol       Date:  2008-06-12       Impact factor: 7.486

4.  miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.

Authors:  Ronglin Zhai; Xuefeng Kan; Bo Wang; Hansong Du; Yueping Long; Heshui Wu; Kaixiong Tao; Guobin Wang; Lihong Bao; Fen Li; Wanli Zhang
Journal:  Tumour Biol       Date:  2014-08-15

5.  Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

Authors:  Jinfeng Huang; Yue Wang; Yingjun Guo; Shuhan Sun
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

7.  MicroRNA-152 targets ADAM17 to suppress NSCLC progression.

Authors:  Yunshu Su; Yuchang Wang; Hongmin Zhou; Lei Lei; Lijun Xu
Journal:  FEBS Lett       Date:  2014-04-26       Impact factor: 4.124

8.  MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17.

Authors:  Yang Wu; Aixue Huang; Tao Li; Xueting Su; Hongmei Ding; Hui Li; Xingliang Qin; Lubin Hou; Qiang Zhao; Xingfeng Ge; Tao Fang; Rong Wang; Changqing Gao; Jie Li; Ningsheng Shao
Journal:  FEBS Lett       Date:  2014-05-08       Impact factor: 4.124

9.  MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.

Authors:  Weidong Ji; Lei Yang; Jianhui Yuan; Linqing Yang; Mei Zhang; Defeng Qi; Xiaolu Duan; Aiguo Xuan; Wenjuan Zhang; Jiachun Lu; Zhixiong Zhuang; Guohua Zeng
Journal:  Carcinogenesis       Date:  2012-11-03       Impact factor: 4.944

Review 10.  Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis.

Authors:  Mark Harries; Martin Gore
Journal:  Lancet Oncol       Date:  2002-09       Impact factor: 41.316

View more
  29 in total

1.  Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure.

Authors:  Thomas J LaRocca; Timon Seeger; Maricela Prado; Isaac Perea-Gil; Evgenios Neofytou; Brigham H Mecham; Mohamed Ameen; Alex Chia Yu Chang; Gaurav Pandey; Joseph C Wu; Ioannis Karakikes
Journal:  Circ Heart Fail       Date:  2020-03-12       Impact factor: 8.790

2.  MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.

Authors:  Wen Qin; Wei Xie; Qinglin He; Tianwei Sun; Chaoguo Meng; Kunling Yang; Yuanfu Luo; Dongmei Yang
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

3.  miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5.

Authors:  Lina Li; Cuiling Wu; Yue Zhao
Journal:  Oncol Lett       Date:  2017-04-18       Impact factor: 2.967

4.  Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors:  Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.

Authors:  Abhishek Shetty; Thejaswini Venkatesh; Shama Prasada Kabbekodu; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Arch Gynecol Obstet       Date:  2022-02-18       Impact factor: 2.493

6.  The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.

Authors:  Rady E El-Araby; Mahmoud A Khalifa; Mona M Zoheiry; Manal Y Zahran; Mohamed I Rady; Raafat A Ibrahim; Mohamed D El-Talkawy; Faiza M Essawy
Journal:  Cancer Gene Ther       Date:  2019-07-18       Impact factor: 5.854

7.  IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.

Authors:  Yi-Yang Wen; Wei-Tao Liu; Hao-Ran Sun; Xin Ge; Zhu-Mei Shi; Min Wang; Wei Li; Jian-Ying Zhang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

8.  MicroRNA profile for health risk assessment: Environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery.

Authors:  Julian Krauskopf; Theo M de Kok; Dennie G Hebels; Ingvar A Bergdahl; Anders Johansson; Florentin Spaeth; Hannu Kiviranta; Panu Rantakokko; Soterios A Kyrtopoulos; Jos C Kleinjans
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

9.  Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma.

Authors:  Ying-Ying Kang; Yang Liu; Ming-Li Wang; Min Guo; Yan Wang; Zhi-Feng Cheng
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

10.  Evaluating the prognostic value of miR-148/152 family in cancers: based on a systemic review of observational studies.

Authors:  Fujiao Duan; Weigang Liu; Xiaoli Fu; Yajing Feng; Liping Dai; Shuli Cui; Zhenxing Yang
Journal:  Oncotarget       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.